The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy
NCT: NCT03582891 · ACTIVE_NOT_RECRUITING
Brief Summary
This is an exploratory pilot study to identify neural correlates of specific motor signs in Parkinson's disease (PD) and dystonia, using a novel totally implanted neural interface that senses brain activity as well as delivering therapeutic stimulation. Parkinson's disease and isolated dystonia patients will be implanted unilaterally or bilaterally with a totally internalized bidirectional neural interface, Medtronic Summit RC+S. This study includes three populations: ten PD patients undergoing deep brain stimulation in the subthalamic nucleus (STN), ten PD patients with a globus pallidus (GPi) target and five dystonia patients. All groups will test a variety of strategies for feedback-controlled deep brain stimulation, and all patients will undergo a blinded, small pilot clinical trial of closed-loop stimulation for thirty days.
Frequently Asked Questions
What is The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy?
The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy is a clinical trial registered under NCT03582891. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03582891?
The current status of NCT03582891 (The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy) is: ACTIVE_NOT_RECRUITING.
When did The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy start?
The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy started on 2018-10-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.